Publication in The Lancet: natural history of Alzheimer’s disease in people with Down syndrome

Down - Sant Pau Memory Unit - The Lancet

Publication in The Lancet The Lancet, a world reference journal in Medicine, publishes the article “Clinical and Biomarker changes of Alzheimer’s disease in adults with Down syndrome: a cross-sectional study“, led by the Alzheimer Down Unit of the Hospital de Sant Pau and the Down Syndrome Catalan Foundation, in collaboration with researchers from the University … Read more Publication in The Lancet: natural history of Alzheimer’s disease in people with Down syndrome

Recommendations to protect people with Down syndrome against COVID-19

covid down t21RS

The coronavirus outbreak COVID-19, which has been listed as a pandemic by the World Health Organization, affects especially vulnerable people and those with previous illnesses. While there is still no evidence on how coronavirus COVID-19 disease affects people with Down syndrome, we know that, in general, people with Down syndrome may have some underlying factors … Read more Recommendations to protect people with Down syndrome against COVID-19

International registry of people with Down syndrome and coronavirus

The Alzheimer-Down Unit (Catalan Down Syndrome Foundation and Hospital de la Santa Creu i Sant Pau) participates in an international registry of people with Down syndrome affected by the coronavirus COVID-19 infection. This registry is powered by the Scientific Society for the Study of Trisomy 21 (T21 Research Society). The objective is to know the … Read more International registry of people with Down syndrome and coronavirus

A blood biomarker can detect Alzheimer’s disease in adults with Down syndrome

Blood and CSF biomarkers in Down Syndrome - Sant Pau Memory Unit - Alzheimer Research - Barcelona

The Alzheimer – Down Unit, that comprises researchers from the Sant Pau Memory Unit of the Neurology Service at Hospital de la Santa Creu i Sant Pau and the Fundació Catalana Síndrome de Down, has published the results of a study of biomarkers in blood and cerebrospinal fluid of adults with Down syndrome in the … Read more A blood biomarker can detect Alzheimer’s disease in adults with Down syndrome

Alzheimer-Down Unit

In collaboration with Fundació Catalana Síndrome de Down Life expectancy in people with Down syndrome has increased significantly over the last few decades, currently reaching an average of 65 years of age. This tremendous success has unfortunately led to the emergence of new aging-related medical issues, particularly Alzheimer’s disease, in this population. Down syndrome can … Read more Alzheimer-Down Unit

SPIN cohort

Volunteer - Sant Pau Memory Unit - Alzheimer Research - Barcelona

Sant Pau Initiative on Neurodegeneration 1. What is the SPIN cohort? The main objective of the SPIN cohort (Sant Pau Initiative on Neurodegeneration) is to widen our knowledge of neurodegenerative diseases such as Alzheimer’s disease, Lewy body dementia and frontotemporal lobe degeneration, through the study of biochemical and neuroimaging markers (also known as biomarkers). This … Read more SPIN cohort